HI SB 2505
died on adjournmentRELATING TO OPIOID USE DISORDER TREATMENT.
Hawaii · 2026 Regular Session · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did HI SB 2505 pass?
No. HI SB 2505 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-02-17): Reported from HHS (Stand. Com. Rep. No. 2297) with recommendation of passage on Second Reading, as amended (SD 1) and referral to JDC/WAM.
What is HI SB 2505 about?
Authorizes licensed paramedics in a county with a population of 100,000 or less to administer buprenorphine after administration of an opioid antagonist in cases of opioid overdoses, under certain conditions. Requires the Department of Health to implement a two-year phased pilot program beginning in one county with a population of 100,000 or less and authorizes expansion of the program statewide as additional treatment resources become available. Requires a report to the Legislature evaluating program outcomes. Appropriates funds. Sunsets 6/30/2028. (SD1)
Who sponsors HI SB 2505?
KOUCHI is the primary sponsor of HI SB 2505.
Description
Authorizes licensed paramedics in a county with a population of 100,000 or less to administer buprenorphine after administration of an opioid antagonist in cases of opioid overdoses, under certain conditions. Requires the Department of Health to implement a two-year phased pilot program beginning in one county with a population of 100,000 or less and authorizes expansion of the program statewide as additional treatment resources become available. Requires a report to the Legislature evaluating program outcomes. Appropriates funds. Sunsets 6/30/2028. (SD1)
- Introduced
- 2026-01-23
- Latest action
- 2026-02-17 — Reported from HHS (Stand. Com. Rep. No. 2297) with recommendation of passage on Second Reading, as amended (SD 1) and referral to JDC/WAM.
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- KOUCHIprimary
Committees
Not provided by source.
Action timeline
Newest first
2026-02-17
Reported from HHS (Stand. Com. Rep. No. 2297) with recommendation of passage on Second Reading, as amended (SD 1) and referral to JDC/WAM.
2026-02-17
Report adopted; Passed Second Reading, as amended (SD 1) and referred to JDC/WAM.
passage,reading-2,referral-committee
2026-02-04
The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 5 Aye(s): Senator(s) San Buenaventura, McKelvey, Kanuha, Keohokalole, Fevella; Aye(s) with reservations: none ; 0 No(es): none; and 0 Excused: none.
committee-passage-favorable
2026-02-03
Re-Referred to HHS, JDC/WAM.
referral-committee
2026-01-30
The committee(s) on HHS has scheduled a public hearing on 02-04-26 1:01PM; Conference Room 225 & Videoconference.
2026-01-28
Referred to HHS, WAM.
referral-committee
2026-01-23
Introduced.
introduction
2026-01-23
Passed First Reading.
reading-1
Versions
Documents
Votes
The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS.
2026-02-04 · pass · 5-0
Member-level votes (5)
- San Buenaventura: yes
- McKelvey: yes
- Kanuha: yes
- Keohokalole: yes
- Fevella: yes
Related bills
- Companion bill: HB 2063
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:20:09.051962Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=HI&identifier=SB 2505. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.